cx-8998
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2017 (NCT03101241)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cx-8998
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03436953 | Phase 2 | Dec 31, 2018 | Cavion LLC |
| NCT03406702 | Phase 2 | Feb 25, 2018 | Cavion LLC |
| NCT03101241 | Phase 2 | May 1, 2017 | Cavion LLC |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cavion LLC | For profit | 3 | 3 | 1 | 2017 |
1 organizations
Page 1 / 1